Literature DB >> 12609271

Long-term effects of 24-month treatment with vagus nerve stimulation on behaviour in children with Lennox-Gastaut syndrome.

A P. Aldenkamp1, H J.M. Majoie, M W. Berfelo, S M.A.A. Evers, A G.H. Kessels, W O. Renier, J Wilmink.   

Abstract

The long-term effects of vagus nerve stimulation (VNS) on behaviour were studied in 19 children with Lennox-Gastaut syndrome. We used the following stimulation parameters: output current: 112 to 2mA; signal frequency: 30Hz frequency; signal pulse width: 500&mgr;s; signal 'on and off' time: 30s 'on,' 3min 'off.' The test battery consisted of cognitive tests assessing mental age and quality of life measurements assessing independency, behavioural problems, and mood. The results show relatively small changes in the behavioural outcomes, concurrent with the modest effects of VNS on seizure frequency (an average of 20.6% seizure reduction). When baseline measurements are compared with the follow-up measures, neither the cognitive measure nor the quality of life measures show any deterioration and the cognitive measure (mental age) showed mild positive changes (gain of 4.2 months mental age during the follow-up period). None of the changes were statistically significant. Treatment effect was most prominent in the group with the highest mental age at baseline, which suggests that mental retardation is a negative prognostic factor for VNS treatment. Moreover, in this specific patient group, treatment effect did not increase with treatment duration. Some evidence during follow-up suggests a direct positive effect of VNS on behavioural function, independent of changes in seizure frequency. Long-term treatment with VNS is not associated with adverse behavioural effects. Mental retardation is a negative prognostic factor for the efficacy of VNS.

Entities:  

Year:  2002        PMID: 12609271     DOI: 10.1016/s1525-5050(02)00517-6

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  10 in total

1.  Vagus nerve stimulation: effectiveness and tolerability in patients with epileptic encephalopathies.

Authors:  Ricardo O Cersósimo; Marcelo Bartuluchi; Cecilia De Los Santos; Irene Bonvehi; Hugo Pomata; Roberto H Caraballo
Journal:  Childs Nerv Syst       Date:  2010-10-31       Impact factor: 1.475

2.  The P3 event-related potential is a biomarker for the efficacy of vagus nerve stimulation in patients with epilepsy.

Authors:  Leen De Taeye; Kristl Vonck; Marlies van Bochove; Paul Boon; Dirk Van Roost; Lies Mollet; Alfred Meurs; Veerle De Herdt; Evelien Carrette; Ine Dauwe; Stefanie Gadeyne; Pieter van Mierlo; Tom Verguts; Robrecht Raedt
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

3.  Vagus nerve stimulation (VNS) is effective in treating catastrophic 1 epilepsy in very young children.

Authors:  Nelia Zamponi; Franco Rychlicki; Ludovica Corpaci; Elisabetta Cesaroni; Roberto Trignani
Journal:  Neurosurg Rev       Date:  2008-04-30       Impact factor: 3.042

Review 4.  Vagus nerve stimulation in the treatment of refractory epilepsy.

Authors:  Andrew H Milby; Casey H Halpern; Gordon H Baltuch
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

5.  Can we predict the response in the treatment of epilepsy with vagus nerve stimulation?

Authors:  A Arcos; L Romero; M Gelabert; A Prieto; J Pardo; X Rodriguez Osorio; M A Arráez
Journal:  Neurosurg Rev       Date:  2014-05-18       Impact factor: 3.042

6.  Diagnosis and management of epileptic encephalopathies in children.

Authors:  Puneet Jain; Suvasini Sharma; Manjari Tripathi
Journal:  Epilepsy Res Treat       Date:  2013-07-22

7.  Vagus nerve stimulation for genetic epilepsy with febrile seizures plus (GEFS+) accompanying seizures with impaired consciousness.

Authors:  Ryosuke Hanaya; Fajar H Niantiarno; Yumi Kashida; Hiroshi Hosoyama; Shinsuke Maruyama; Toshiaki Otsubo; Kazumi Tanaka; Atsushi Ishii; Shinichi Hirose; Kazunori Arita
Journal:  Epilepsy Behav Case Rep       Date:  2016-11-09

8.  Vagus nerve stimulation in patients with Lennox-Gastaut syndrome: A meta-analysis.

Authors:  Maxine Dibué; Teresa Greco; Jochem K H Spoor; Zubair Tahir; Nicola Specchio; Daniel Hänggi; Hans-Jakob Steiger; Marcel A Kamp
Journal:  Acta Neurol Scand       Date:  2020-12-01       Impact factor: 3.209

9.  Treatment of Lennox-Gastaut syndrome: overview and recent findings.

Authors:  Kenou van Rijckevorsel
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

Review 10.  Surgical treatment of pediatric epileptic encephalopathies.

Authors:  J Fridley; G Reddy; D Curry; S Agadi
Journal:  Epilepsy Res Treat       Date:  2013-10-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.